Physician profile
Jan Franko
NPI 1023218286
$2,439.33
in general payments reported to CMS, 2019-2025
10 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $167 · 2021: $182 · 2022: $394 · 2023: $151 · 2024: $265 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922 · Travel and Lodging: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.63 |
| Travel and Lodging | $617.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $1,037.38 | 2025 | |
| Intuitive Surgical, INC. | $343.74 | 2021-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $323.61 | 2019-2025 | Echelon; Endopath, Echelon Circular |
| Medtronic, INC. | $274.53 | 2021-2025 | Valleylab Ft10 |
| Sirtex Medical INC | $137.74 | 2024 | Sir-Spheres Microspheres |
| Carl Zeiss Meditec, INC. | $108.93 | 2019 | |
| Conmed Corporation | $66.67 | 2020 | |
| Lemaitre Vascular, INC. | $66.15 | 2024 | Artegraft Vascular Graft |
| Tela Bio, INC. | $42.80 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Galvanize Therapeutics, INC | $37.78 | 2023 | Aliya System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Franko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.